Ads
related to: biogen's biib
Search results
Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
Zacks via Yahoo Finance· 5 months agoBiogen (BIIB) gets positive CHMP opinion recommending marketing authorization to Skyclarys in the EU...
Biogen's (BIIB) ALS Drug Tofersen Filing Accepted in Europe
Zacks via Yahoo Finance· 1 year agoBiogen BIIB announced that the European Medicines Agency (EMA) has accepted the marketing...
Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects
Zacks via Yahoo Finance· 1 year agoDetailed data from Biogen (BIIB) and Eisai's Clarity AD shows that treatment with lecanemab in the...
Biogen's (BIIB) FDA Filing for ALS Drug Gets 3 Months Extension
Zacks via Yahoo Finance· 2 years agoThe FDA extends the review period for Biogen's (BIIB) NDA for tofersen in SOD1-ALS. This extension...
Biogen's (NASDAQ:BIIB) underlying earnings growth outpaced the favorable return generated for...
Simply Wall St. via Yahoo Finance· 11 months agoThe simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right...
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Motley Fool· 9 months agoBiogen's (NASDAQ: BIIB) biggest problem in recent times has been growth. The biotech giant's...
Biogen's (NASDAQ:BIIB) investors will be pleased with their favorable 64% return over the last year
Simply Wall St. via Yahoo Finance· 1 year agoPassive investing in index funds can generate returns that roughly match the overall market. But you...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 3 weeks agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 4 weeks agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Simply Wall St. via Yahoo Finance· 1 year agoBiogen's (NASDAQ:BIIB) stock is up by a considerable 12% over the past month. As most would know,...
